Summary

for people ages 55 years and up (full criteria)
at La Jolla, California and other locations
study started
estimated completion:

Description

Summary

This study will assess the safety and efficacy of the brimonidine intravitreal implant in patients with geographic atrophy due to age-related macular degeneration.

Keywords

Geographic Atrophy Macular Degeneration Atrophy Brimonidine Tartrate 400 µg Brimonidine Implant Sham

Eligibility

You can join if…

Open to people ages 55 years and up

  • Geographic atrophy due to age-related macular degeneration in the study eye
  • Visual acuity better than or equal to 20/125 in the study eye and 20/200 in the fellow eye

You CAN'T join if...

  • Cataract surgery or Laser-Assisted in situ Keratomileusis (LASIK) in the study eye in the last 3 months
  • Infections in either eye in the last 3 months

Locations

  • University of California, San Diego, Jacobs Retina Center, Shiley Eye Center
    La Jolla California 92093 United States
  • Retinal Consultants of Arizona, Ltd., Retinal Research Institute
    Phoenix Arizona 85014 United States
  • Associated Retina Consultants
    Phoenix Arizona 85020 United States
  • Northern California Retina Vitreous Associates
    Mountain View California 94040 United States
  • Retina Consultants of Southern Colorado, PC
    Colorado Springs Colorado 80909 United States
  • Oregon Retina, LLP
    Eugene Oregon 97401 United States
  • Casey Eye Institute, Oregon Health and Science University
    Portland Oregon 97239 United States
  • Retina Research Institute of Texas
    Abilene Texas 79606 United States
  • Strategic Clinical Research Group, LLC
    Willow Park Texas 76087 United States
  • "Austin Retina Associates "
    Austin Texas 78705 United States
  • Texas Retina Associates
    Arlington Texas 76012 United States
  • Retina Foundation of the Southwest
    Dallas Texas 75231 United States
  • Valley Retina Institute
    McAllen Texas 78503 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Allergan
Links
More Information
ID
NCT02087085
Phase
Phase 2
Study Type
Interventional
Last Updated
July 2017